Erleada 60 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F7UU0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,966
Award facts
- Contract value 100% obligated
- $7,965.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Erleada 60 mg tablets (120-count units) with a ceiling value of $7,965.80 and a firm fixed-price contract type. This delivery order, which is not set-aside, is expected to be completed by January 22, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vehicle designated SPE2DX that extends through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant role in federal medical procurement through its DLA contracts, which encompass a wide range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's demonstrated capability to fulfill federal requirements through open competition, combined with its extensive portfolio of delivery orders at varying price points, positions it as a critical vendor for military and veteran healthcare systems. This specific delivery order for Erleada, a prostate cancer treatment, reflects the company's ongoing supply of specialized pharmaceutical products to support Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F7UU0?
SPE2DR26F7UU0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F7UU0 worth?
The government has obligated $7,966 on SPE2DR26F7UU0.
Is contract SPE2DR26F7UU0 an order under another contract?
Yes. SPE2DR26F7UU0 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UU0 competed?
The extent of competition for SPE2DR26F7UU0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award